Health & Personal Care
HIGH
FDA DRUG
Sandoz Recalls Cyclophosphamide Injection Over Safety Concerns
Sandoz Inc. recalled 263 vials of Cyclophosphamide Injection on September 5, 2025. The recall follows cGMP deviations related to temperature excursions during transportation. Healthcare providers and consumers must stop using the product immediately.
Sandoz
cGMP deviations: